1. Home
  2. IMXI vs PCRX Comparison

IMXI vs PCRX Comparison

Compare IMXI & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMXI
  • PCRX
  • Stock Information
  • Founded
  • IMXI 1994
  • PCRX 2006
  • Country
  • IMXI United States
  • PCRX United States
  • Employees
  • IMXI N/A
  • PCRX N/A
  • Industry
  • IMXI Retail: Computer Software & Peripheral Equipment
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMXI Technology
  • PCRX Health Care
  • Exchange
  • IMXI Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • IMXI 302.5M
  • PCRX 1.2B
  • IPO Year
  • IMXI N/A
  • PCRX 2011
  • Fundamental
  • Price
  • IMXI $10.67
  • PCRX $23.21
  • Analyst Decision
  • IMXI Buy
  • PCRX Buy
  • Analyst Count
  • IMXI 7
  • PCRX 9
  • Target Price
  • IMXI $19.60
  • PCRX $29.89
  • AVG Volume (30 Days)
  • IMXI 350.6K
  • PCRX 582.1K
  • Earning Date
  • IMXI 08-06-2025
  • PCRX 07-29-2025
  • Dividend Yield
  • IMXI N/A
  • PCRX N/A
  • EPS Growth
  • IMXI 1.60
  • PCRX N/A
  • EPS
  • IMXI 1.70
  • PCRX N/A
  • Revenue
  • IMXI $652,547,000.00
  • PCRX $702,772,000.00
  • Revenue This Year
  • IMXI N/A
  • PCRX $7.54
  • Revenue Next Year
  • IMXI $3.03
  • PCRX $10.78
  • P/E Ratio
  • IMXI $6.23
  • PCRX N/A
  • Revenue Growth
  • IMXI N/A
  • PCRX 3.08
  • 52 Week Low
  • IMXI $9.76
  • PCRX $11.16
  • 52 Week High
  • IMXI $22.38
  • PCRX $29.33
  • Technical
  • Relative Strength Index (RSI)
  • IMXI 50.26
  • PCRX 35.28
  • Support Level
  • IMXI $9.76
  • PCRX $23.24
  • Resistance Level
  • IMXI $10.49
  • PCRX $24.36
  • Average True Range (ATR)
  • IMXI 0.37
  • PCRX 0.74
  • MACD
  • IMXI 0.07
  • PCRX -0.13
  • Stochastic Oscillator
  • IMXI 67.66
  • PCRX 15.58

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: